Halberd antibacterial monoclonal antibody

Halberd antibacterial monoclonal antibody refers to a suite of monoclonal antibodies developed by Halberd Corporation targeting various pathogenic bacteria, including Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. These antibodies are engineered to bind specifically to bacterial surface antigens, thereby neutralizing the pathogens or marking them for removal. A key application of these antibodies is their integration into Halberd's extracorporeal treatment process, where they are used to capture and eliminate bacteria and their associated toxins from a patient's bloodstream. The development is primarily focused on addressing antibiotic-resistant infections and sepsis.

Other names

Halberd's antibacterial monoclonal antibodyHalberd antibacterial mAbHalberd universal antibacterial monoclonal antibody